reference/7995613

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7995613

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	836
issn	0732-183X 1527-7755
issueIdentifier	8
pageRange	830-836
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	830
bibliographicCitation	Salit RB, Fowler DH, Wilson WH, Dean RM, Pavletic SZ, Dunleavy K, Hakim F, Fry TJ, Steinberg SM, Hughes TE, Odom J, Bryant K, Gress RE, Bishop MR. Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignancies. J Clin Oncol. 2012 Mar 10;30(8):830–6. PMID: 22312100; PMCID: PMC3295571.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3e1086080f38ff9311c5116b3b2f816 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e6b1ffb0f175e9b77fd4b067c7292b4b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c859f36c0d1d28dbd292cab89bf5b96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_417716cdf8669dd2a37c10615f76b1aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a45e93b440ec995ef4c19b75ea8abf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8280d01d37dc15a2953fa7eecc343669 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0667bfbf7117f7d8e2f0aa843ae753e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_605550b4a05fc8a2e5fb7a56394bef78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_febd35880b3bc5f928aaab7f46cb8217 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2e543e1427d44722cfb023b9db1f523b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e3100a947ae132c1a991c5b1bbbf2d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f879a66ff5b9f9435d14b71f879bbf3d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50655c4dcc944a8ab6094b4af95e23fc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7543b4921be9a949fb5f4fd13d1a8f1
date	2012-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2011.37.0296 https://pubmed.ncbi.nlm.nih.gov/PMC3295571 https://pubmed.ncbi.nlm.nih.gov/22312100
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/0732-183X https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Dose-Adjusted EPOCH-Rituximab Combined With Fludarabine Provides an Effective Bridge to Reduced-Intensity Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Lymphoid Malignancies
discusses	http://id.nlm.nih.gov/mesh/M0024273 http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0028879 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0244307 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0082555 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0022659 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0007930 http://id.nlm.nih.gov/mesh/M0544940
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018380 http://id.nlm.nih.gov/mesh/D016879Q000379 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D008223Q000628
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000069283 http://id.nlm.nih.gov/mesh/D015851Q000097 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D058846Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D003520Q000633 http://id.nlm.nih.gov/mesh/D019409Q000097 http://id.nlm.nih.gov/mesh/D005047Q000008 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D000970Q000633 http://id.nlm.nih.gov/mesh/D008212 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D005434 http://id.nlm.nih.gov/mesh/D014740Q000008 http://id.nlm.nih.gov/mesh/D011241Q000633 http://id.nlm.nih.gov/mesh/D005047Q000633 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D014740Q000633 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D014750Q000633 http://id.nlm.nih.gov/mesh/D014740Q000031 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D058846Q000633 http://id.nlm.nih.gov/mesh/D004317Q000633 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008223Q000401 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000971Q000633
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_877d039c22ad8f6cdf6db3b86d13009b http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID657237 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814614 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281

Total number of triples: 107.